Target intelligence / Profile preview

Opsin protein

Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Opsin proteins are a diverse group of G protein-coupled receptors (GPCRs) that serve as light-sensitive receptors in animal tissues, most prominently in the photoreceptor cells of the retina[1][5][8]. Each opsin consists of seven transmembrane helices and binds a chromophore (typically 11-cis-retinal), which, upon photon absorption, isomerizes and triggers a conformational change, activating the G protein-mediated signal transduction pathway fundamental to vision and other light-responsive biological processes[1][8][5]. In vertebrates, they enable sight, while non-visual opsins (such as melanopsin) are crucial for circadian rhythm regulation and other non-image-forming photoreceptive functions[1][3]. Opsins are organized into multiple subfamilies according to sequence, G-protein-coupling specificity, and biological role; their functional diversity covers vision, circadian entrainment, pigmentation, taste, thermosensation, and more[3][7]. Opsin mutations are implicated in retinal dystrophies, color vision deficiencies, and may affect circadian behaviors; while no direct drugs target opsins clinically, they are central to optogenetic research where engineered opsins allow light-based modulation of cellular signaling[2][3][8].

Other names
Visual pigment proteinRetinylidene proteinPhotopigmentGPCR rhodopsin family protein
02

Mechanism of action

Light activation causing isomerization of chromophore, initiating G protein signaling cascades - In optogenetics, activation by light enables remote control of cell signaling

03

Biological functions

Signal transductionPhotoreceptionVisionCircadian rhythm regulationSensory perception (e.g., light, taste, temperature)
04

Disease associations

Neurodegenerative diseaseVision disorders (e.g., retinitis pigmentosa, color blindness)Other (potential roles in circadian rhythm and certain behavioral disorders)
05

Safety considerations

Off-target effects in gene therapy (e.g., immune reactions)Aberrant signaling from mutations may lead to photoreceptor degenerationLack of specificity in drug or cell therapy delivery
06

Interacting drugs

None approved as direct opsin modulators; research tools (e.g. retinal analogues, photoswitchable ligands) and gene therapies exist
07

Biomarkers

Opsin gene mutations (e.g., rhodopsin mutations) as biomarkers for inherited retinal diseasesOpsin expression profiles for photoreceptor health and circadian rhythm disorders

Beyond the preview

Go deeper on Opsin protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opsin protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call